To understand the molecular mechanism of NR2F2 in breast cancer, we determined the cistrome and transcriptome of NR2F2 in the ER-positive breast cancer cell lines (MCF-7 and T47D) using the chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) and RNA-seq methods. Here, NR2F2 is linked to breast carcinoma.